Vitrafy Life Sciences Ltd. ( (AU:VFY) ) has shared an update.
Vitrafy Life Sciences Limited has released its Q3 FY25 Investor Presentation, highlighting its ongoing efforts to optimize cryopreservation technology. The company’s innovative approach combines advanced hardware and software integration, which is expected to enhance the reliability and efficiency of maintaining biological assets. This development may strengthen Vitrafy’s position in the market by offering comprehensive solutions to industries reliant on the preservation of biological samples.
More about Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Limited is a company specializing in cryopreservation solutions, offering a proprietary range of smart cryopreservation hardware and a cloud-based software platform called Lifechain™. This integrated system is designed to preserve the quality of biomaterials, ensuring the integrity of sensitive biological samples during storage. The company is headquartered in Melbourne, Australia, and operates an ISO13485 accredited manufacturing facility and laboratory in Ballarat, Victoria. Vitrafy is listed on the Australian Securities Exchange under the ticker VFY.
Average Trading Volume: 29,424
Learn more about VFY stock on TipRanks’ Stock Analysis page.